Follow us on Twitter: @CanadianGastric
Home
Patients
Past research
View highlights of significant research in the field of gastric cancer
Ongoing trials
British Columbia
Alberta
Manitoba
Saskatchewan
Ontario
Quebec
Maritimes
Informational resources
Glossary
Non-Curative Treatments
Nutrition
Gastrectomy
Providers
Become a Member
Membership Directory
Newsletter Archive
Support the CaGCA
Home
Patients
Past research
View highlights of significant research in the field of gastric cancer
Ongoing trials
British Columbia
Alberta
Manitoba
Saskatchewan
Ontario
Quebec
Maritimes
Informational resources
Glossary
Non-Curative Treatments
Nutrition
Gastrectomy
Providers
Become a Member
Membership Directory
Newsletter Archive
Support the CaGCA
Search:
Glossary
Home
»
Patients
»
Informational resources
»
Glossary
“-ectomy”
“gastr-”
Adverse effects
Angiogenesis
Benign
Cancer
CDH1 mutation
Cell
Chemoradiotherapy
Clinical practice guidelines
Compliance
Control group
Cytoreductive Surgery (CRS)
Disease-free survival
Distal
Distal Gastrectomy
Drug Trial Phases
Esophagocardiac resection
First line therapy
Gastrectomy
Gastroesophageal junction
Gastrointestinal (GI) tract
Genetic mutation
HER-2
High-risk
Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
Impact Factor
Intention to treat (ITT)
Intraoperative Frozen Resection
Laparoscopic surgery
Long-term outcomes
Lymph Nodes
Lymphadenectomy
Malignant
Median survival
Metastasectomy
Metastasis
Minimally invasive
Neoadjuvant Intraperitoneal Systemic chemotherapy (NIPS)
Overall survival
Performance status
Perioperative
Peritoneum
Post-operative complications
Postoperative
Preoperative
Primary research
Primary Site
Prophylactic gastrectomy
Proximal
Proximal Gastrectomy
Quality of life
R-0 Margins
Radiation therapy
Randomized
Randomized Controlled Trial
Reattachment
Relapse
Resectable gastric cancer
Screening
Second line therapy
Secondary research
Secondary site
Short-term outcomes
Standard of care
Surveillance
Systematic review
TNM System
Total gastrectomy
